Sankara Eye Hospital Hosts Workshop to Strengthen Patient Safety and Infection Prevention

IMT News Desk
IMT News Desk
· 2 min read
KIMS Hospitals Bengaluru launches the Institute of Advanced Neurosciences, a new Centre of Excellence featuring state-of-the-art neurosurgery

Sankara Eye Hospital, Hyderabad, organized the “CSSD 360: Standardize, Sterilise, Safeguard” workshop, underscoring the critical role of the Central Sterile Supply Department (CSSD) in ensuring patient safety and preventing healthcare-associated infections.

The program was conducted by Sankara Eye Hospital under the guidance of Dr. Sai Shruthi, Chief Microbiologist.

Dr. Sriram Simakurthy, Chief Medical Officer, Sankara Eye Hospital, highlighted the indispensable role of CSSD in clinical care, particularly in ophthalmology, where even minimal contamination can lead to severe complications.

The scientific sessions featured insights from an esteemed panel of national and international experts. Dr. Vijendra Kawle, Consultant Microbiologist, Rainbow Children’s Hospital, elaborated on CSSD fundamentals and workflow optimization. Dr. Safaa Muneer Ahmed, Group Head at Microbiology and Infection Control, Renova Hospitals, spoke on microbiological considerations and infection prevention strategies.

Mr. Shailesh Mehta, Director, Medovation Inc., presented on kill kinetics and sterilization validation processes, while Dr. Ramakrishna Pai, Additional Professor, AIIMS Mangalagiri, discussed advancements in cleaning, disinfection, and sterilization technologies.

Further strengthening the discussions, Dr. Pragathi K., Senior Consultant Microbiologist and Infection Control Officer at AIG Hospitals, addressed quality management systems in CSSD. Dr. Mustafa Afzal, Consultant Microbiologist and Infection Control Officer at Care Hospitals, provided insights into regulatory standards and guidelines, including NABH and JCI requirements.

Dr Sriram Simakurthy said that “In ophthalmic care, precision is everything and that extends beyond the surgeon’s skill to the sterility of every instrument used. Even the smallest lapse in sterilization can have serious consequences for patient outcomes. Strengthening CSSD systems is not optional; it is fundamental to delivering safe and high-quality eye care.”

Dr. Clive Graham, Consultant Microbiologist from the NHS, United Kingdom, shared international best practices and their applicability in the Indian healthcare context.

The workshop featured interactive discussions and case-based learning sessions, enabling participants to engage actively and gain practical insights into real-world challenges and solutions in sterilization practices.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk